Skip to search formSkip to main contentSkip to account menu

INS-365

Known as: INS 365, INS365 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Diquafosol

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Effects of Dinucleoside Polyphosphates on Trabecular Meshwork Cells and Aqueous Humor Outflow Facility
The most important risk factor for the development of glaucoma is elevated intraocular pressure (IOP). Hypotensive drugs decrease… 
2005
2005
Diquafosol Tetrasodium (INS365) Treatment and Corneal Clearing: Evidence from Clinical Trials
2003
2003
Diquafosol Tetrasodium (INS365) Ophthalmic Solution is Not Absorbed Systemically in Patients with Dry Eye
2003
2003
Selective P2Y2 receptor agonists stimulate vaginal moisture in ovariectomized rabbits
As many as 10 million American women 50 to 74 years of age describe reduced vaginal lubrication, uncomfortable or frankly painful… 
Review
2003
Review
2003
Diquafosol tetrasodium. Inspire/Allergan/Santen.
Inspire, in collaboration with Allergan and Santen, is developing an eye-drop formulation of diquafosol tetrasodium (INS-365), a… 
2002
2002
Next-Generation P 2 Y 2 Receptor Agonist for the Treatment of Cystic Fibrosis
  • 2002
  • Corpus ID: 31632360
INS37217 [P-(uridine 5 )-P-(2 -deoxycytidine 5 )tetraphosphate, tetrasodium salt] is a deoxycytidine-uridine dinucleotide with… 
2000
2000
P2Y2 AGONIST, INS365: A POTENTIAL DRY EYE THERAPEUTIC AGENT.
1999
1999
A breath of fresh air for patients with lung disease?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)